A mysterious and resilient adenovirus is spreading worldwide, raising concerns among health experts due to its lack of specific antiviral treatment. The virus, which has over 60 strains, can cause a range of symptoms from mild cold-like illness to severe complications in vulnerable groups.
Dr. Eric Sachinwalla, medical director of infection prevention and control at Jefferson Health, warns that while most healthy individuals experience only mild symptoms, the elderly, pregnant women, and those with weakened immune systems face higher risks. Unlike flu or COVID-19, adenovirus is unusually hardy, surviving on surfaces for extended periods and resisting soap, water, and standard disinfectants.
The virus spreads easily through close contact and can mimic other illnesses, making early detection challenging. Symptoms vary by strain but commonly include fever, sore throat, and respiratory issues. Most people recover within two days with rest, but fevers reaching 40°C require medical attention.
Experts attribute the rise in cases to factors such as a surge in flu in the southern hemisphere and lower flu vaccination rates, which may increase overall vulnerability. Public health officials emphasize hygiene, avoiding close contact with sick individuals, and monitoring symptoms, especially for at-risk populations.
Currently, no specific antiviral treatment exists for adenovirus, and care is supportive. Vigilance and preventive measures are key to controlling its spread.
